Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.
DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.
Interfacing soft actuators with biological nervous systems remains a major challenge in flexible bioelectronics. Here, we present the first in-vivo neural control of compliant reinforced dielectric elastomer actuators (rDEAs) functioning as implanted artificial muscles. To establish the clinical benchmark for this platform , we targeted the reanimation of facial paralysis, a condition requiring soft, low-force actuation. Pre-clinical in-vitro testing on anatomically realistic human skull models demonstrates that rDEAs can reproduce smiling displacements, achieving 14% strain under physiologically relevant loads. To validate core bio-electronic viability, the encapsulated, fiber-reinforced rDEAs were implanted subcutaneously in an anesthetized rat model. The devices generated controlled and repeatable tissue displacements up to 0.78 mm at 7 kV, utilizing ultrasound gel to successfully overcome biological tissue damping. When interfaced with the sciatic nerve via flexible cuff electrodes, the actuators responded in real-time to efferent neural signals, enabling synchronized movement. Furthermore, because rDEAs operate as compliant capacitors, maintaining the electrostatically ’acti-vated’ state required for resting facial symmetry draws near-zero steady-state power. This first in-vivo demonstration establishes a robust bioelectronic platform for neuro-controlled artificial muscles, marking a critical step toward the dynamic reanimation of paralyzed tissues.